PRECISION ENTERIC MEDICINE

WIPO WIPO 2019

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark PRECISION ENTERIC MEDICINE was filed as Word mark on 10/17/2019 at the World Intellectual Property Organization.

Trademark Details Last update: July 27, 2022

Trademark form Word mark
File reference 1501199
Countries Australia Canada Switzerland China European Community United Kingdom Israel Japan South Korea Mexico Norway New Zealand Russia Singapore
Base trademark US No. 88393454, April 19, 2019
Application date October 17, 2019
Expiration date August 23, 2021

Trademark owner

20 Acorn Park Drive
Cambridge MA 02140
US

Trademark representatives

600 Atlantic Avenue Boston MA 02210-2206 US

goods and services

05 Therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use
42 Research and development in the field of computational biology, biotechnology and pharmaceuticals

Trademark history

Date Document number Area Entry
May 7, 2022 2022/26 Gaz US RAW: Total Ceasing Effect
January 27, 2022 2022/4 Gaz JP Rejection
January 18, 2022 2022/4 Gaz CA Rejection
August 6, 2021 2021/33 Gaz IL Rejection
June 24, 2021 2021/30 Gaz AU Rejection
June 22, 2021 2021/29 Gaz SG Rejection
April 9, 2021 2021/15 Gaz CH Rejection
April 7, 2021 2021/15 Gaz CA Rejection
April 1, 2021 2021/14 Gaz KR Rejection
February 18, 2021 2021/7 Gaz JP Rejection
February 1, 2021 2021/5 Gaz RU Rejection
December 10, 2020 2021/1 Gaz NO Rejection
October 29, 2020 2020/45 Gaz EM Rejection
October 29, 2020 2020/46 Gaz CH Rejection
October 13, 2020 2020/42 Gaz KR Rejection
September 15, 2020 2020/39 Gaz GB Rejection
June 26, 2020 2020/27 Gaz NO Rejection
May 29, 2020 2020/23 Gaz RU Rejection
May 11, 2020 2020/21 Gaz CN Rejection
May 3, 2020 2020/19 Gaz IL Rejection
April 21, 2020 2020/17 Gaz NZ Rejection
March 17, 2020 2020/12 Gaz AU Rejection
January 15, 2020 2020/4 Gaz SG Rejection
December 20, 2019 2019/52 Gaz EM Rejection
December 7, 2019 2019/50 Gaz GB Rejection
October 17, 2019 2019/47 Gaz US Registration

ID: 141501199